Did they say BOM2, finally! Good to get an extension and to know that Hepalink are on side. Next sign of progress will be a significant share price increase from these ridiculous levels. At least we are in a industry that has a ton of cash to put to work. So let's get a clinical study going and no more science papers for now. Fully utilize our BTD to our advantage.